4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-054693
Chairman and CEO bought 5,500 shares at an average $2.69 ($14,815)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2019-10-30 | Purchase | +3,500 | $2.57 | $8,995 | 10,269,393 | D |
| Niihara Yutaka Chairman and CEO | 2019-10-31 | Purchase | +2,000 | $2.91 | $5,820 | 10,271,393 | D |
| Open-market purchases · 5,500 sh · avg $2.69 · $14,815 | |||||||
Loading xslF345X03/doc4.xml…